Send a message.
We’re here to answer any question you may have.
Contact
For business, media, or testing-related inquiries, please get in touch.
We’re here to answer any question you may have.
For business, media, or testing-related inquiries, please get in touch.
Follow C-POLAR Technologies’ Latest Product Developments, Partnerships, And Implementations
May 8, 2023 - St. Paul's Cardiologist Dr. Alan Rabinowitz and Sam Chung of C-POLAR Technologies discuss the practical application of new technology to eradicate airborne diseases in healthcare settings.
Northumberland, 22 March 2023 - C-POLAR Technologies, Inc., an international bioprotection leader offering revolutionary protection against viruses, bacteria, molds, fungi, and pollens, and its wholly owned subsidiary, C-POLAR Ireland Ltd., announced today that they have established a UK office at the Northumbria Healthcare Manufacturing and Innovation Hub in Seaton Delaval, Northumberland. These facilities will play a key part in the process for creating and applying the C-POLAR™ polymer to existing and future products with an intention to have the ‘plant-based polymer’ plants located in the UK.
“Northumbria is committed to bringing innovations to the NHS to help ensure the health and wellbeing of our healthcare professionals and patients, all while generating additional revenue for the NHS,” said Andrew Edmunds, director of innovation at Northumbria Healthcare NHS Foundation Trust. “Our initial partnership is a great step towards enabling us to use C-POLAR Technologies to create safer environments, from ambulances to hospital wards, that are consistently free from pathogens, while providing income back to the public sector.”
C-POLAR Technologies supports reinvestment back into public health and plans to share a significant portion of its profits with the NHS. This will provide much-needed capital to improve patient care and services in the UK. The public-private collaboration is unique in the healthcare industry and will set a new standard for government and private business.
C-POLAR™ is a non-toxic, non-metallic, plant-based food additive polymer that is 100% natural and approved by the World Health Organization (WHO) and the United Nations Food and Agricultural Organization (FAO).
C-POLAR™ — which stands for cationic polarization — is based on fundamental physics. Extensive testing and more than 200 commercial installations across Hong Kong, Canada, and the U.S. show that when C-POLAR™ is applied to materials, textiles, and healthcare products, they are imbued with a stable positive charge that effectively captures and eradicates viruses, microorganisms, and pollens. The application functions as an essential interrupter. Here is a link to a short video that shows how the technology works.
“If we learned anything from the last few years, it’s that while face masks and vaccines are critically important, they aren’t enough to break the chain of infectious spread,” said Dr. Michael Mansour, associate professor of medicine at Harvard Medical School and assistant physician in infectious disease at Massachusetts General Hospital. “Many common and uncommon pathogens do not have a vaccine. Collectively, we need to be more inventive and leverage innovative solutions that can protect us by interrupting actual transmission.”
C-POLAR Technologies has more than 30 products both commercialized and in the production pipeline, including personal protective wear, face masks, air purifiers, catheters and other medical devices, room furnishings (e.g., hospital curtains, bedding, wall hangings), surgical gloves, and paint. This large product suite, coupled with its unlimited future potential, has enabled C-POLAR Technologies to partner with several NHS entities to reduce the risk of infections for staff and patients of the NHS.
Additional new agreements to benefit the NHS community and beyond:
###
About C-POLAR Technologies, Inc.
C-POLAR Technologies, Inc., is a global company with headquarters in the United States, a research and development center in Canada, and European offices in Ireland & the United Kingdom. It is an international bioprotection leader offering revolutionary protection against viruses, microorganisms, and fungi amid the rising prevalence of global outbreaks. C-POLAR™ — which stands for cationic polarization — is based on fundamental physics. Studies show that when C-POLAR™ is applied to selected materials, the materials are imbued with a stable positive charge that effectively captures and eradicates 99.99% of viruses, bacteria, molds, fungi, and pollens. C-POLAR™ creates and enables infection-resilient environments of the future — setting a new global standard for health and safety for governments, private enterprises, hospitals, and schools. To learn more, visit the company’s website at cpolartechnologies.com.
APR 28
2023
PR
INTERNATIONAL BUSINESS TIMES
C-POLAR Technologies is combating airborne infections with the development of polymer-protected air filters.
MAR 22
2023
PR
PR NEWSWIRE
Northumbria Healthcare NHSFT and C-POLAR Technologies combine innovation in widely acclaimed hub.
JUL 5
2022
PR
FINANCIAL POST
Top international academic institutions complete independent studies validating
C-POLAR™ Technology.
JUN 29
2022
Implementation
HONG KONG BAPTIST HOSPITAL
Hong Kong Baptist Hospital Applies Antiviral and Antibacterial Air Filtration Invention, C-POLAR™, to Enhance Protection for Patients and Staff.
APR 12
2022
PR
HONG KONG METROPOLITAN UNIVERSITY
Hong Kong Secretary for Innovation and Technology visits Hong Kong Metropolitan University, meets with C-POLAR™.
MAR 22
2023
PR
PR NEWSWIRE
Northumbria Healthcare NHSFT and C-POLAR Technologies combine innovation in widely acclaimed hub.
MAR 30
2022
Implementation
HANG LUNG PROPERTIES
Hang Lung Properties adopts C-POLAR™ to promote customer tenant and employee wellbeing across its designated medical hubs in Hong Kong.
MAR 2
2022
Awards
HONG KONG AWARDS FOR INDUSTRIES
C-POLAR (formerly Curie Limited) wins the Innovation and Creativity Grand Award from the Hong Kong Awards for Industries.
NOV 28
2021
Awards
HONG KONG ICT AWARDS
C-POLAR wins the 2021 Smart Living Grand Award from the Hong Kong ICT Awards.
SEP 16
2021
PR
PR NEWSWIRE
C-POLAR participates in the HICOOL 2021 Global Entrepreneurship Competition, wins third prize.
AUG 5
2021
PR
BBC NEWS
Gateshead NHS Trust first to make its own masks, uses C-POLAR™ material as antiviral layer.
AUG 5
2021
PR
ITV NEWS
NHS in Gateshead & Northumberland uses C-POLAR™ material to make COVID-19 FFP3 masks.
AUG 4
2021
Implementation
QE FACILITIES
QE Facilities is leading the way, becoming the first NHS body to start to manufacture FFP3 masks protected by C-POLAR™ in the UK.
JUN 22
2021
Awards
THE HONG KONG INSTITUTION OF ENGINEERS
C-POLAR wins the 2021 Hong Kong Enginpreneurs Award, sponsored by the Hong Kong Institution of Engineers.
Adding {{itemName}} to cart
Added {{itemName}} to cart